TREACE MEDICAL CONCEPTS INC (TMCI)
US89455T1097 - Common Stock
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
Treace Medical Concepts Breaks Above 200-Day Moving Average - Bullish for TMCI
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base...
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
TMCI Crosses Below Key Moving Average Level
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
Treace Appoints Guy Guglielmino as Chief Commercial Officer
Treace Appoints Guy Guglielmino as Chief Commercial Officer
PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
Treace Announces Participation at Stifel 2024 Healthcare Conference
Treace Announces Participation at Stifel 2024 Healthcare Conference
PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (
Treace Announces Participation in the UBS Global Healthcare Conference
Treace Announces Participation in the UBS Global Healthcare Conference
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
Positions Treace to Significantly Increase Penetration into Overall Bunion Market and Expand Surgeon Customer Base
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
Noteworthy Tuesday Option Activity: FSLR, TMCI, NVRO
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
PONTE VEDRA, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (